C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)

Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)

NCT00653965 ·Status: COMPLETED ·Phase: PHASE3

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

NCT00347217 ·Status: COMPLETED

Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome

NCT00335699 ·Status: COMPLETED ·Phase: PHASE4

Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study

NCT01378715 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)

NCT00462748 ·Status: COMPLETED ·Phase: PHASE3

MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)

NCT01154036 ·Status: COMPLETED ·Phase: PHASE3

Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)

NCT00240266 ·Status: COMPLETED ·Phase: PHASE3

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

NCT05850091 ·Status: RECRUITING ·Phase: PHASE4

Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome

NCT04873934 ·Status: COMPLETED ·Phase: PHASE3

Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal

NCT00240344 ·Status: COMPLETED

Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

NCT00296374 ·Status: COMPLETED ·Phase: PHASE2

CRESTOR Athero Imaging Head to Head IVUS Study

NCT00620542 ·Status: COMPLETED ·Phase: PHASE3

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

NCT00296387 ·Status: COMPLETED ·Phase: PHASE3

High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients

NCT03494270 ·Status: COMPLETED ·Phase: PHASE4

Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque

NCT03169985 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Crestor Versus Placebo in Subjects With Heart Failure

NCT00206310 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)

NCT00654225 ·Status: COMPLETED ·Phase: PHASE3

Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

NCT00446940 ·Status: COMPLETED ·Phase: PHASE2

Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease

NCT00329160 ·Status: COMPLETED ·Phase: PHASE4

COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

NCT00654485 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

NCT03217409 ·Status: COMPLETED ·Phase: PHASE4

ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

NCT00396240 ·Status: WITHDRAWN ·Phase: PHASE4

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

NCT01609907 ·Status: COMPLETED ·Phase: PHASE1

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

NCT00239330 ·Status: COMPLETED ·Phase: PHASE3

To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia

NCT00726362 ·Status: COMPLETED